class="blog wp-embed-responsive wp-theme-foxiz wp-child-theme-foxiz-child supp-body td-standard-pack personalized-all menu-ani-1 hover-ani-1 btn-ani-1 btn-transform-1 is-rm-1 lmeta-dot loader-1 dark-sw-1 mtax-1 is-hd-5 is-backtop none-m-backtop is-mstick is-smart-sticky"
Generally safe at supplemental doses. Chromium picolinate form occasionally associated with DNA damage concerns in vitro — clinical significance uncertain. Theoretical interaction with antidiabetic medications (additive blood glucose lowering).
Chromium is a trace mineral that enhances insulin signalling. EU approved claim: contributes to normal macronutrient metabolism and maintenance of normal blood glucose levels.
Chromium-binding molecule called chromodulin (LMWCr) potentiates insulin receptor tyrosine kinase activity when chromium binds. Increases GLUT4 translocation to cell membranes.
| Population | Safety rating | Max safe dose |
|---|---|---|
| Diabetes | Possibly safe | 200-1000mcg/day with monitoring |
| Enhances insulin sensitivity. Monitor blood glucose closely. | ||
| General | Possibly safe | 200mcg/day |
| No established UL. Very low toxicity from picolinate form. High doses may cause kidney damage. | ||
No peer-reviewed clinical trial data found for this ingredient.
Data by supplement.ge — Public Health Institute of Georgia (PHIG)